News
In this article, we are going to take a look at where Ascendis Pharma A/S (NASDAQ:ASND) stands against the other growth stocks. The market closed last week mostly lower, however, the S&P 500 has ...
Five Danish filmmakers are picking up the baton from the founders of Dogma 95 and launching Dogma 25 along with a new manifesto and ten “vows of chastity” to “protect the artistic integrity ...
In a recent filing with the U.S. Securities and Exchange Commission, Ascendis Pharma (NASDAQ ... in the company’s Articles of Association, 25% of these warrants will vest on the first ...
On Monday, Cantor Fitzgerald reaffirmed its Overweight rating on Ascendis Pharma (NASDAQ: ASND) shares with a $200.00 price target, well above the current trading price of $151.25.
In this article, we are going to take a look at where Ascendis Pharma A/S (NASDAQ ... while popular AI stocks lost around 25%. If you are looking for an AI stock that is more promising than ...
Hosted on MSN14d
Ascendis Pharma launches $25 million share buybackC OPENHAGEN - Ascendis Pharma A/S (NASDAQ:ASND), a biopharmaceutical company valued at $7.15 billion, has initiated a share repurchase program, with plans to buy back up to $18.25 million of its ...
The League of Legends patch 25.11 preview showcases the upcoming changes coming to the Rift. While the meta is in a stable spot after the release of patch 25.10, the developers are looking to buff ...
In a recent filing with the U.S. Securities and Exchange Commission, Ascendis Pharma (NASDAQ ... According to the terms outlined in the company’s Articles of Association, 25% of these warrants will ...
Ascendis Pharma A/S, operates as a biopharmaceutical company that focuses on developing TransCon-based therapies for unmet medical needs in Denmark, rest of Europe, North America, and ...
The much-awaited League of Legends patch 25.10 has been revealed on May 13, 2025. It is the second patch of the ranked season 2, featuring a new game mode named "Brawl," and updates various AP ...
Ascendis Pharma COPENHAGEN, Denmark, May 13, 2025 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced new data showing improvements in growth and bone morphometry from Week 52 ...
We’re excited to introduce Elite Daily’s 25 Under 25 list. Throughout the year, we’ll be shining a spotlight on the young, talented musicians, creators, and athletes who are taking over your ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results